Global Peripheral Arterial Disease (PAD) Therapeutics Industry

News provided by

Reportlinker

29 Aug, 2012, 07:46 ET

NEW YORK, Aug. 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Peripheral Arterial Disease (PAD) Therapeutics Industry

http://www.reportlinker.com/p0960424/Global-Peripheral-Arterial-Disease-PAD-Therapeutics-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

This report analyzes the worldwide markets for Peripheral Arterial Disease (PAD) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 50 companies including many key and niche players such as 7TM Pharma A/S, AnGes MG, Inc., AstraZeneca Plc, CardioVascular BioTherapeutics, Inc., Cytokinetics, Inc., Diffusion Pharmaceuticals LLC, Eli Lilly and Company, LTT Bio-Pharma Co., Ltd., miRagen Therapeutics, Inc., Multi Gene Vascular Systems Ltd., Nissan Chemical Industries, Ltd., Otsuka Pharmaceutical Co., Ltd., Pluristem Therapeutics, Inc., ReNeuron Group PLC., Sanofi , Sucampo Pharmaceuticals, Inc., t2cure GmbH, TCA Cellular Therapy, LLC , TheraVasc, Inc., and vasopharm GmbH. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

To order this report:

Therapy Industry: Global Peripheral Arterial Disease (PAD) Therapeutics Industry

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Also from this source

The Global Online Travel Booking Platform Market is forecast to grow by $1107.21 bn during 2022-2027, accelerating at a CAGR of 14.85% during the forecast period

The Global Smart Home Appliances Market is forecast to grow by $39.91 bn during 2022-2027, accelerating at a CAGR of 14.45% during the forecast period

Explore

More news releases in similar topics

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.